Acceptability of a ‘treat to target’ approach in inflammatory bowel disease to patients in clinical remission

摘要

A ‘treat to target’ approach aiming for remission of clinical symptoms and absence of mucosal inflammation has been proposed in inflammatory bowel disease (IBD). We aimed to establish whether patients with IBD in clinical remission find this approach acceptable.